Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal Indomethacin in Acute Pancreatitis
NCT02692391Phase 3Completed
- Sponsor
- University of Pittsburgh
- Start
- Jul 2013
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute pancreatitis (AP) comparing Indomethacin suppository with Placebo (2 arms). Primary endpoints: Systemic Inflammatory Response Syndrome Score at 48 hours and C-Reactive Protein Levels at 48 hours. Started Jul 2013; status: completed.
02
Drugs
indomethacin
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT02692391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02692391.